why choose us

Clinical Trials Search

Showing 16,770 of 132,963 result(s)
Cognitive Rehabilitation for Long COVID

Status: COMPLETED

Condition: Long COVID

Interventions: A strategy-focused intervention aimed at improving everyday cognitive function, structured to maximize treatment dose over a short time period.
T

Date: 2023-01-04

Social Determinants of Sleep and Obesity

Status: COMPLETED

Condition: Insufficient Sleep
Physical Inactivity
Sedentary Behavior
Obesity

Interventions: BEHAVIORAL: Sleep intervention - The sleep extension intervention is a 4-week intervention consisting of weekly one-on-one contact with the goal of in

Date: 2023-01-04

Safety, Tolerability and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients.

Status: COMPLETED

Condition: Alzheimer's Disease

Interventions: Multiple-ascending Dose

Date: 2023-01-04

A Clinical Study of Nemtabrutinib in Japanese Participants With Hematological Malignancies (MK-1026-002)

Status: COMPLETED

Condition: Mature B-cell Neoplasms

Interventions: Nemtabrutinib tablets will be administered orally QD at dosage of 45 mg or 65 mg

Date: 2023-01-04

Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P)

Status: COMPLETED

Condition: Anaemia

Interventions: Daprodustat will be administered up to Week 52.

Date: 2023-01-04

To Compare the Safety and Efficacy of Balloon Occluded;Plug Assisted Retrograde Transvenous Obliteration With Endoscopic Variceal Obturation for Primary Prophylaxis of Gastric Varices With Large Spontaneous Shunt

Status: COMPLETED

Condition: Liver Cirrhosis

Interventions: Balloon occluded;plug assisted retrograde transvenous obliteration will be done one time only.

Date: 2023-01-03

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Status: Completed

Condition: Borderline Resectable Pancreatic Adenocarcinoma

Interventions: Undergo collection of blood and tissue samples

Date: 2023-01-03

Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation

Status: Completed

Condition: Recurrent Transformed Chronic Lymphocytic Leukemia

Interventions: Undergo tumor biopsy

Date: 2023-01-03

Regulatory T Cells for Amyotrophic Lateral Sclerosis

Status: Completed

Condition: Amyotrophic Lateral Sclerosis

Interventions: CK0803 (cryopreserved, allogeneic, cord blood derived T regulatory cells that express neurotropic homing markers) will be administered intravenously

Date: 2023-01-03